Hospital-Based Clinical Pharmacy Services to Improve AmbulatoryManagement of Chronic Obstructive Pulmonary Disease

摘要

>Background: No systematic evaluations of a comprehensive clinical pharmacy process measures currently exist to determine an optimal ambulatory care collaboration model for chronic obstructive pulmonary disease (COPD) patients. >Objective: Describe the impact of a pharmacist-provided clinical COPD bundle on the management of COPD in a hospital-based ambulatory care clinic. >Methods: This retrospective cohort analysis evaluated patients with COPD managed in an outpatient pulmonary clinic. The primary objective of this study was to assess the completion of 4 metrics known to improve the management of COPD: (1) medication therapy management, (2) quality measures including smoking cessation and vaccines, (3) patient adherence, and (4) patient education. The secondary objective was to evaluate the impact of the clinical COPD bundle on clinical and economic outcomes at 30 and 90 days post–initial visit. >Results: A total of 138 patients were included in the study; 70 patients served as controls and 68 patients received the COPD bundle from the clinical pharmacist. No patients from the control group had all 4 metrics completed as documented, compared to 66 of the COPD bundle group (P < .0001). Additionally, a statistically significantdifference was found in all 4 metrics when evaluated individually. Clinicalpharmacy services reduced the number of phone call consults at 90 days(P = .04) but did not have a statistically significantimpact on any additional pre-identified clinical outcomes.>Conclusion: A pharmacist-driven clinical COPD bundle wasassociated with significant increases in the completion and documentation of 4metrics known to improve the outpatient management of COPD.